Glooko Device System for Glooko Application
by Glooko, Inc.
510(k) K132272
Glooko Device System for Glooko Application is a medical device (FDA Class II; FDA product code NBW, System, Test, Blood Glucose, Over The Counter) made by Glooko, Inc., cleared under FDA 510(k) K132272 on 17 Oct 2013, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK132272 | Date17 Oct 2013 | StatusActive |
Official records
- FDA 510(k) database K132272
From the FDA record
- Received by the FDA
- 22 Jul 2013
- FDA decision
- 17 Oct 2013 (Substantially Equivalent)
- FDA review time
- 87 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- NBW
- Device class
- Class II
- Regulation
- 21 CFR Part 862.1345
- Advisory committee
- Clinical Chemistry
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code NBW (System, Test, Blood Glucose, Over The Counter).
- PRODIGY AUTOCODE EJECT BLOOD GLUCOSE MONITORING SYSTEM by OK BIOTECH CO., LTD.
- GLUCOLEADER ENHANCE SELF-MONITORING OF BLOOD GLUCOSE SYSTEM by HMD BIOMEDICAL INC.
- GLUCODR SUPERSENSOR SYSTEM by All Medicus Co., Ltd.
- On Call Express Mobile Blood Glucose Monitoring System by Acon Laboratories, Inc.
- CONTOUR® PLUS BLUE Blood Glucose Monitoring System by Ascensia Diabetes Care
- StatStrip Xpress Blood Glucose Monitoring System by NOVA BIOMEDICAL CORPORATION
- INTOUCH DIABETES by Symcare Personalized Health Solutions, Inc.
- MEDISIGN BLOOD GLUCOSE MONITORING SYSTEM by Tianjin Empecs Medical Device Co., Ltd.
- AG-608N BLOOD GLUCOSE MONITORING SYSTEM by Andon Medical Co., Ltd.
- CARESENS N LINK BLOOD GLUCOSE MONITORING SYSTEM; CARESENS N LINK MULTI BLOOD BLUCOSE MONITORING SYSTEM by i-SENS, Inc.